Spyre Therapeutics stock dips premarket after Friday surge as $500 million shelf hangs over shares
Spyre Therapeutics dropped 4.2% to $41.38 in premarket action Monday, after its last trade came in at $43.21.
Shan Ahmed Khan is a senior markets reporter at TS2.tech. His coverage ranges from stocks and technology to economic developments across global markets. He worked in investment research and market analysis before becoming a financial journalist and is a graduate of the Lahore University of Management Sciences (LUMS).
